• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Omeros Corporation (OMER)

    -NasdaqGM
    15.50 Down 0.26(1.65%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:15.76
    Open:15.57
    Bid:14.80 x 100
    Ask:15.63 x 400
    1y Target Est:47.17
    Beta:2.59739
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:14.92 - 15.89
    52wk Range:11.18 - 30.23
    Volume:967,759
    Avg Vol (3m):1,200,860
    Market Cap:587.23M
    P/E (ttm):N/A
    EPS (ttm):-2.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OMERDown 1.65%587.23M
    ACADUp 0.69%3.84B
    ALKSUp 3.24%9.43B
    HRTXUp 0.28%N/A

    Key Statistics

    Forward P/E (1 yr):140.91
    P/S (ttm):150.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.83
    Quarterly EPS Est (Sep-15) :-0.47
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback